[Skip to Navigation]
Sign In
Viewpoint
November 10, 2015

Predicting the Overuse of PCSK-9 Inhibitors

Author Affiliations
  • 1Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota
  • 2Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota
  • 3Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
JAMA. 2015;314(18):1909-1910. doi:10.1001/jama.2015.13414
Add or change institution
×